CardiologyOnline.net

Cardiology Xagena

Xagena Mappa
Xagena Newsletter
OncologiaMedica.net
Medical Meeting

Search results for "Ezetimibe"

The SEAS ( Simvastatin and Ezetimibe in Aortic Stenosis ) study has investigated the effects of intensive cholesterol lowering with the combination of Simvastatin ( 40 dmg daily ) and Ezetimibe ( 10 m ...


Of the theoretical estimated prevalence of 1/500 for heterozygous familial hypercholesterolaemia, less than 1% are diagnosed in most countries. Direct screening in a Northern European general populati ...


Amgen has announced that the phase 3 GAUSS-2 ( Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects-2 ) trial evaluating Evolocumab in patients with high cholesterol w ...


A study looking at the data of thousands of patients who suffered myocardial infarctions has suggested treatment with high-potency statins offers a significantly improved chance of survival compared t ...


Ezetimibe ( Ezetrol, Zetia ) reduces low-density lipoprotein cholesterol ( LDL-C ) but has complex actions on cholesterol transport and metabolism, and thus, LDL-C reduction may not solely define its ...


A study has determined all-cause mortality in patients with a first myocardial infarct who were treated with Simvastatin ( Zocor ) compared with high-potency statin and Simvastatin / Ezetimibe ( Vytor ...


A investigational IMPROVE-IT study has met its primary and all secondary composite efficacy endpoints. Treatment with Simvastatin in combination with Ezetimibe ( Vytorin ) has significantly reduced ca ...


IMPROVE-IT ( IMProved Reduction of Outcomes: VYTORIN Efficacy International Trial ), was an international, multi-center, randomised, double-blind active comparator trial of 18,144 high-risk patients p ...


The IMPROVE-IT study met its primary and all secondary composite efficacy endpoints. In IMPROVE-IT, patients taking the LDL-cholesterol-lowering medicine Vytorin ( Ezetimibe / Simvastatin ), which com ...


Recent trials have shown a reduction in the risk of major adverse cardiac events ( MACE ) with Simvastatin and Ezetimibe ( Vytorin ) therapy in patients with acute coronary syndrome. The potential be ...


The first aim was to critically evaluate the extent to which familial hypercholesterolaemia ( FH ) is underdiagnosed and undertreated. The second aim was to provide guidance for screening and treatmen ...


In statin trials, men and women have shown similar relative risk reductions in cardiovascular events per 39 mg/dL low-density lipoprotein cholesterol ( LDL-C ) reduction. Researchers have assessed wh ...


Subcutaneous administration of Inclisiran, a small-interfering RNA ( siRNA ) directed against proprotein convertase subtilisin/kexin type 9 ( PCSK9 ), was associated with substantial and sustained low ...